34º Congresso Mineiro de Cardiologia
Acesse o site do congresso
1º Dia - 7/10/25
2º Dia - 7/11/25
3º Dia - 7/12/25

Aula SC 7B: Disfunção ventricular no paciente oncológico Voltar

Ariane Scarlatelli Macedo

Sessão científica 7: Cardio-oncologia - Frank Nunes e Themissa Helena Voss

Artigo Autor(es) Referência
A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. Lewinter Christian, Nielsen Torsten Holm, Edfors Lars Robert, Linde Cecilia, Bland John Martin, LeWinter M, Cleland John G F, Køber Lars, Braunschweig Frieder, Mansson-Broberg Agneta European heart journal. 2022 Jul; 43(Jul):2562-2569. doi: 10.1093/eurheartj/ehab843. pii: .
Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Faggiano Andrea, Gherbesi Elisa, Giordano Chiara, Gamberini Giacomo, Vicenzi Marco, Cuspidi Cesare, Carugo Stefano, Cipolla Carlo M, Cardinale Daniela M Cancers. 2024 Nov; 16(Nov):doi: 10.3390/cancers16223883. pii: 3883.
Clinical Practice Guidelines in Cardio-Oncology. Leong Darryl P, Lenihan Daniel J Heart failure clinics. 2022 Jul; 18(Jul):489-501. doi: 10.1016/j.hfc.2022.02.002. pii: S1551-7136(22)00003-4.
Detection of right ventricular dysfunction by three - dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy. El-Sherbeny Wafaa S, Sabry Nesreen M, El-Saied Shaimaa B, Elnagar Basma Cardio-oncology (London, England). 2023 Apr; 9(Apr):20. doi: 10.1186/s40959-023-00169-y. pii: 20.
Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments. Pons-Riverola Alexandra, Morillas Herminio, Berdejo Javier, Pernas Sonia, Pomares Helena, Asiain Leyre, Garay Alberto, Fernandez-Ortega Adela, Oliveira Ana Carla, Martínez Evelyn, Jiménez-Marrero Santiago, Pina Elena, Fort Eduard, Ramos Raúl, Alcoberro Lídia, Hidalgo Encarnación, Antonio-Rebollo Maite, Alcober Laia, Enjuanes Grau Cristina, Comín-Colet Josep, Moliner Pedro Cancers. 2023 Dec; 15(Dec):doi: 10.3390/cancers15245885. pii: 5885.
Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients. Lal Jessica C, Fang Michelle Z, Hussain Muzna, Abraham Abel, Tonegawa-Kuji Reina, Hou Yuan, Chung Mina K, Collier Patrick, Cheng Feixiong Cardio-oncology (London, England). 2025 Feb; 11(Feb):17. doi: 10.1186/s40959-025-00309-6. pii: 17.
Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant? Kenigsberg Benjamin, Wellstein Anton, Barac Ana JACC. Heart failure. 2018 Feb; 6(Feb):87-95. doi: 10.1016/j.jchf.2017.08.024. pii: S2213-1779(17)30622-4.
Management of Chemotherapy-Induced Left Ventricular Dysfunction and Heart Failure in Patients With Cancer While Undergoing Cancer Treatment: The MD Anderson Practice. Fadol Anecita P Frontiers in cardiovascular medicine. 2018 ; 5():24. doi: 10.3389/fcvm.2018.00024. pii: 24.
Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapy. Yao Ren Jie Robert, Gibson Jordan, Simmons Christine, Davis Margot K Cardio-oncology (London, England). 2021 Mar; 7(Mar):12. doi: 10.1186/s40959-021-00099-7. pii: 12.
Predicting Left Ventricular Dysfunction in Childhood Cancer Survivors: In Search of the Echocardiography Holy Grail. Border William L, Effinger Karen E, Leger Kasey J JACC. CardioOncology. 2023 Aug; 5(Aug):486-488. doi: 10.1016/j.jaccao.2023.07.003. pii: .
Nenhuma revista foi definida para este congresso.